Supplements to protect muscle while taking semaglutide
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether taking HMB and vitamin D can help older adults with type 2 diabetes keep their muscle mass while they start taking semaglutide for weight loss. It may help prevent muscle loss during weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 85 years old.
- You have type 2 diabetes, with an HbA1c of 6.5% or higher, or you currently take medication for diabetes.
- Your body mass index (BMI) is 27 or higher.
- You are just starting to take semaglutide (like Ozempic or Wegovy) under your doctor's care.
- You are able to walk 400 meters (about a quarter mile) without help, though using a cane is okay.
- You speak English, because all study materials are in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This trial tests if adding a natural compound called 20E (20-hydroxyecdysone) to the weight-loss drug semaglutide can help people with obesity lose more weight and keep muscle. You would take both medications and follow a diet and exercise plan.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial studies how brown fat (a type of body fat) changes after starting semaglutide for weight loss. You may help researchers understand how this medication affects the body’s energy use, which could improve weight-loss treatments.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.